Skip to main content

Animations

MJFF Publications

651 - 660 of 6433 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Transcriptional signatures in iPSC-derived neurons are reproducible across labs when differentiation protocols are closely matched
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.scr.2021.102558
    Citation Count: 5
  • Summary Details
    OPEN
    Title: The International Parkinson Disease Genomics Consortium Africa
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00100-9
    Citation Count: 24
  • Summary Details
    OPEN
    Title: The mechanisms of smell loss after SARS-CoV-2 infection
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00202-7
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00214-3
    Citation Count: 424
  • Summary Details
    OPEN
    Title: High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis
    Journal Name: eClinicalMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.eclinm.2021.100988
    Citation Count: 110
  • Summary Details
    OPEN
    Title: Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
    Journal Name: Frontiers in Cell and Developmental Biology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fcell.2020.615461
    Citation Count: 124
  • Summary Details
    OPEN
    Title: Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2021.626128
    Citation Count: 81
  • Summary Details
    OPEN
    Title: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s13311-022-01199-7
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England
    Journal Name: PharmacoEconomics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40273-022-01132-y
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synuclein
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-022-07706-2
    Citation Count: 13
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.